VSY Biotechnology, with its slogan "We are proud of inspiring to see better and to move better. We inspire to live better. #weinspire," is a progressive and innovative company in the biotechnology, fashion, healthcare, manufacturing, and medical devices industries. Founded in 2009 and headquartered in Germany, the company is dedicated to customer satisfaction through the creation of state-of-the-art ophthalmology products designed to enhance and improve vision for patients globally. The company's commitment to innovation is evident in its rigorous research and development process, ensuring manufacturing efficiency and the highest optic quality for its products. Specializing in cataract products and improvements to existing intraocular lens models, VSY Biotechnology offers monofocal and multifocal IOLs in different platforms, including Modified C, Balance, and Plate Haptic. Additionally, the company manufactures foldable scleral fixation lens, viscoelastics, and injector and cartridge systems for cataract surgery. While VSY Biotechnology prioritizes customer satisfaction and trust, it also aims to lead the global market in providing ophthalmology products and brands at the forefront of innovation. Continuous advancements in technology and a focus on customer needs position the company as a key player in the ophthalmology industry.
There is no investment information
No recent news or press coverage available for VSY Biotechnology GmbH.